KRISTEN LEE: Open Payments
NPI 1871665299 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 59 payments from 11 companies in 2025. Trend: 2023 $715 · 2024 $1,021 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $578 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $177 |
| Lilly USA, LLC | 5 | $133 |
| Janssen Biotech, Inc. | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| GENZYME CORPORATION | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $14 |
Products named: RINVOQ, OMVOH, DUPIXENT, ENTYVIO, TREMFYA, SKYRIZI, MAVYRET, CREON.
Industry payments across WA — which companies pay providers there.
